Pm. Vandiemen et al., IMMUNE-RESPONSES OF PIGLETS TO PASTEURELLA-MULTOCIDA TOXIN AND TOXOID, Veterinary immunology and immunopathology, 41(3-4), 1994, pp. 307-321
Experimental atrophic rhinitis (AR), serum antibody titres and in vitr
o lymphoproliferation to Pasteurella multocida derived toxin (Pm-T) we
re studied in piglets. Specific immune responses to Pm-T and Pm-T indu
ced conchae atrophy were compared with AR immunity. This immunity was
initiated by the Nobi-VAC(R) AR-T vaccine administered at various time
s with respect to Pm-T challenge. Animals challenged with Pm-T develop
ed conchae atrophy, but no antibodies nor cellular immune responses to
Pm-T were detected. Vaccination 3 weeks before Pm-T challenge protect
ed pigs against breakdown of nasal bony tissues. This protection was a
ccompanied by an increase of serum antibodies and in vitro lymphoproli
feration to Pm-T. Animals vaccinated 10 days before or after Pm-T chal
lenge also had antibodies and cellular immune responses. However, thes
e animals developed AR. In vitro, Pm-T appeared mitogenic for quiescen
t (non-immune) peripheral lymphocytes and Concanavalin A stimulated ly
mphocytes from some pigs. These in vitro lymphoproliferative responses
could be partly abrogated by the addition of monomorphic anti-swine m
ajor histocompatibility complex class II Do and DR specific monoclonal
antibodies. We conclude that Pm-T is poorly immunogenic in vivo and d
oes not initiate a protective Pm-T specific immune response. Pigs were
protected from AR by vaccination, but protection was dependent on the
timing of vaccine administration. We speculate that Pm-T modifies the
immune response such that the response is not directed towards the to
xin but to an unidentified component in the nose of piglets.